While the first reference human genome is more than 20 years old (Skaletsky et al, 2003), the reference human genome GRCh38 Y chromosome was missing almost half of its 57.2 Mb. But the August 23 online publication of...read more
Latest news and insights
Changing the Clinical Genetic Testing Paradigm to Increase Sensitivity and Specificity
The goal of clinical genomics is to provide a diagnosis for difficult-to-solve inherited and somatic disorders to enhance a personalized therapeutic approach. Unfortunately, despite costly and extensive testing only...read more
The Role of the Human Gut Microbiome in Alzheimer’s Disease Development
Alzheimer’s disease (AD), today is the most prevalent form of dementia afflicting more than 50 million people worldwide (Queiroz et al., 2022, Varesi et al., 2022), and with a doubling time of 20 years could easily...read more
The Cheap Genome Is Not Enough – We Need an “Accurate and Good Genome”
We may still be five Years out until We Can Sequence Everyone I had the chance to attend the Precision Medicine World Conference PMWC 2023 SV in the last couple of days. Some 2,000+ individuals from across the life...read more
ONTOFORCE Wants to Increase Data Literacy and Empower Citizen Data Scientists
This month’s “Company Spotlight” provides a closer look at ONTOFORCE, the creator of a semantic search technology platform for insight generation. I spoke with Valerie Morel, CEO of ONTOFORCE, about ONTOFORCE’s platform...read more
UK GENOMICS SPOTLIGHT Report: LEADING INNOVATIONS 2022
Published by the UK Department for International Trade (DIT) in partnership with the ABHI (Association British HealthTech Industries), BIA (BioIndustry Association), Genomics England, and the NHS England and NHS...read more
Omicron NTD Insertions: A new Route for Variant Generation?
My most recent article published was a quick review of what was known about the SARS Omicron variant in the post 2021, The Year of the Various SARS-CoV-2 Variants of Concern – from Alpha to Omicron. While researching...read more
We Invite you to join enlightenbio’s Subject Matter Expert Network!
enlightenbio is a boutique consultancy providing product strategy and market intelligence to precision medicine industries. Our mission is to help our clients successfully develop, launch, and market exceptional...read more
Truwl is on a Mission to Make Bioinformatics Comprehensible and Accessible
This latest interview is with Karl Sebby, the CEO of Truwl. Truwl is an exciting, relatively new bioinformatics company that engages in accelerating and simplifying biological research. Truwl is also the name of the...read more
2021, The Year of the Various SARS-CoV-2 Variants of Concern – from Alpha to Omicron
A review of the various SARS-CoV-2 Omicron mutations 2021 was the year of multiple variants of concerns (VOCs) starting with the Alpha variant in the UK, which was first detected in November 2020, and spread quickly by...read more
